| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 1.04e-12 | 279 | 103 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 6.68e-10 | 4 | 103 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 6.68e-10 | 4 | 103 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 8.17e-10 | 10 | 103 | 5 | GO:0004062 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B RASGEF1B TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 8.91e-10 | 507 | 103 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B RASGEF1B TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 8.91e-10 | 507 | 103 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.33e-09 | 5 | 103 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.12e-09 | 13 | 103 | 5 | GO:0050656 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.31e-08 | 7 | 103 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B ABHD5 TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 4.07e-08 | 656 | 103 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | sulfate binding | 8.25e-08 | 9 | 103 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 9.39e-06 | 55 | 103 | 5 | GO:0008146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 4.02e-05 | 74 | 103 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B ABHD5 TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 1.82e-04 | 1233 | 103 | 17 | GO:0140677 |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 2.61e-04 | 5 | 103 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E RANBP1 TBC1D3 TBC1D3H TBC1D3L RGPD8 TBC1D3D RGPD1 ADGRB3 TBC1D3C TBC1D3B ABHD5 RASGEF1B TBC1D3I TBC1D3G TBC1D3K TBC1D3F RGPD5 | 3.18e-04 | 1418 | 103 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 1.98e-03 | 13 | 103 | 2 | GO:0005078 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 7.94e-12 | 109 | 104 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 3.04e-09 | 5 | 104 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.74e-08 | 17 | 104 | 5 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.74e-08 | 17 | 104 | 5 | GO:0034035 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.29e-08 | 244 | 104 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | sulfation | 2.19e-07 | 27 | 104 | 5 | GO:0051923 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.02e-06 | 335 | 104 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.38e-06 | 17 | 104 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.77e-06 | 18 | 104 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.02e-06 | 23 | 104 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.61e-05 | 106 | 104 | 6 | GO:0034308 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 3.42e-05 | 121 | 104 | 6 | GO:0006576 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.43e-05 | 13 | 104 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 3.62e-05 | 74 | 104 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 3.62e-05 | 74 | 104 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 4.38e-05 | 499 | 104 | 11 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E ERBB4 TBC1D3 TBC1D3H TBC1D3L SASH1 RGPD8 TBC1D3D RGPD1 TBC1D3C TBC1D3B PRKCQ TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.50e-05 | 1028 | 104 | 16 | GO:0043085 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 5.94e-05 | 195 | 104 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 7.19e-05 | 201 | 104 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0034032 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 9.08e-05 | 362 | 104 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 9.21e-05 | 47 | 104 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 1.05e-04 | 148 | 104 | 6 | GO:0009308 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.33e-04 | 20 | 104 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.37e-04 | 52 | 104 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E ERBB4 TBC1D3 TBC1D3H TBC1D3L SASH1 RGPD8 TBC1D3D ESR2 RGPD1 TBC1D3C TBC1D3B ADD2 PRKCQ TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.69e-04 | 1430 | 104 | 18 | GO:0044093 |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 5.08e-04 | 73 | 104 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 6.19e-04 | 286 | 104 | 7 | GO:0042445 | |
| GeneOntologyBiologicalProcess | nuclear transport | 6.59e-04 | 378 | 104 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 6.59e-04 | 378 | 104 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 6.94e-04 | 381 | 104 | 8 | GO:0048545 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.43e-04 | 141 | 104 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 7.67e-04 | 142 | 104 | 5 | GO:0018958 | |
| MousePheno | abnormal mammary gland morphology | ESR2 SLC30A4 SULT1A2 SULT1A4 SULT1A1 SULT1A3 PROKR2 PXMP2 DGAT1 | 2.11e-06 | 201 | 80 | 9 | MP:0000627 |
| MousePheno | abnormal apocrine gland morphology | ESR2 SLC30A4 SULT1A2 SULT1A4 SULT1A1 SULT1A3 PROKR2 PXMP2 DGAT1 | 2.11e-06 | 201 | 80 | 9 | MP:0013554 |
| MousePheno | enlarged gallbladder | 1.83e-05 | 28 | 80 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 3.17e-05 | 32 | 80 | 4 | MP:0020134 | |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 8.44e-14 | 49 | 100 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.97e-13 | 53 | 100 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.93e-13 | 55 | 100 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.93e-13 | 55 | 100 | 10 | IPR000195 |
| Domain | Ran_BP1 | 3.71e-07 | 12 | 100 | 4 | PF00638 | |
| Domain | RANBD1 | 3.71e-07 | 12 | 100 | 4 | PS50196 | |
| Domain | RanBD | 5.33e-07 | 13 | 100 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 5.33e-07 | 13 | 100 | 4 | IPR000156 | |
| Domain | Sulfotransferase_dom | 1.31e-06 | 36 | 100 | 5 | IPR000863 | |
| Domain | Sulfotransfer_1 | 1.31e-06 | 36 | 100 | 5 | PF00685 | |
| Domain | Grip | 2.38e-05 | 11 | 100 | 3 | SM00755 | |
| Domain | GRIP | 2.38e-05 | 11 | 100 | 3 | PF01465 | |
| Domain | GRIP_dom | 3.16e-05 | 12 | 100 | 3 | IPR000237 | |
| Domain | GRIP | 3.16e-05 | 12 | 100 | 3 | PS50913 | |
| Domain | PH_dom-like | 4.68e-04 | 426 | 100 | 9 | IPR011993 | |
| Domain | GCC2_Rab_bind | 5.86e-04 | 7 | 100 | 2 | IPR032023 | |
| Domain | Rab_bind | 5.86e-04 | 7 | 100 | 2 | PF16704 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TCAP TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 1.19e-10 | 99 | 76 | 10 | M46448 |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 3.88e-09 | 5 | 76 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 5.38e-07 | 13 | 76 | 4 | M18256 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.76e-06 | 17 | 76 | 4 | M39483 | |
| Pathway | WP_ESTROGEN_METABOLISM | 5.30e-06 | 22 | 76 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 6.39e-06 | 23 | 76 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 7.64e-06 | 24 | 76 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.56e-05 | 39 | 76 | 4 | MM15695 | |
| Pathway | WP_RETINOL_METABOLISM | 8.99e-05 | 44 | 76 | 4 | MM15851 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 4.24e-04 | 6 | 76 | 2 | M39437 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.97e-04 | 29 | 76 | 3 | M45015 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.53e-28 | 11 | 108 | 11 | 16863688 |
| Pubmed | 6.55e-11 | 10 | 108 | 5 | 7601475 | ||
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 24318996 | ||
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 33414449 | ||
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 8.79e-11 | 4 | 108 | 4 | 12390022 | |
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 8424956 | ||
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 8288252 | ||
| Pubmed | 8.79e-11 | 4 | 108 | 4 | 25370010 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 3.32e-10 | 13 | 108 | 5 | 17425406 | |
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 11389699 | ||
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 29908303 | ||
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 25053625 | ||
| Pubmed | 4.39e-10 | 5 | 108 | 4 | 24802129 | ||
| Pubmed | 3.06e-09 | 7 | 108 | 4 | 12438748 | ||
| Pubmed | 3.06e-09 | 7 | 108 | 4 | 9370299 | ||
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 3.47e-09 | 74 | 108 | 7 | 16625196 | |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 6.10e-09 | 8 | 108 | 4 | 10594240 | |
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 1.09e-08 | 9 | 108 | 4 | 23207770 | |
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 19548878 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 9177785 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 9166597 | ||
| Pubmed | 1.09e-08 | 9 | 108 | 4 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.09e-08 | 9 | 108 | 4 | 9060415 | |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.85e-08 | 11 | 108 | 4 | 7613026 | |
| Pubmed | 2.85e-08 | 11 | 108 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.85e-08 | 11 | 108 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.85e-08 | 11 | 108 | 4 | 9034160 | |
| Pubmed | 2.85e-08 | 11 | 108 | 4 | 10720750 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 2.91e-08 | 3 | 108 | 3 | 8363592 | |
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 9855620 | ||
| Pubmed | 2.91e-08 | 3 | 108 | 3 | 8912648 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 4.27e-08 | 12 | 108 | 4 | 7706460 | |
| Pubmed | 6.15e-08 | 13 | 108 | 4 | 10585447 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 32152050 | ||
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 8661000 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.16e-07 | 4 | 108 | 3 | 12359748 | |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 8406013 | ||
| Pubmed | 1.17e-07 | 15 | 108 | 4 | 1741163 | ||
| Pubmed | 2.60e-07 | 18 | 108 | 4 | 20056724 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 12604796 | ||
| Pubmed | 2.90e-07 | 5 | 108 | 3 | 8471161 | ||
| Pubmed | 5.05e-07 | 21 | 108 | 4 | 32301970 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.01e-06 | 7 | 108 | 3 | 15710750 | |
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.61e-06 | 8 | 108 | 3 | 21310149 | |
| Pubmed | 2.41e-06 | 9 | 108 | 3 | 10601307 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 3.44e-06 | 10 | 108 | 3 | 11535246 | |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 4.23e-06 | 135 | 108 | 6 | 31077711 | |
| Pubmed | 4.72e-06 | 11 | 108 | 3 | 34110283 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 9.55e-06 | 2 | 108 | 2 | 14871892 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 9.55e-06 | 2 | 108 | 2 | 38069221 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11207031 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 9.55e-06 | 2 | 108 | 2 | 20936502 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 29705271 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 20417180 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 9.55e-06 | 2 | 108 | 2 | 10762004 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10617600 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 9.55e-06 | 2 | 108 | 2 | 23358261 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10543947 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 9.55e-06 | 2 | 108 | 2 | 7581483 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15752422 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 9.55e-06 | 2 | 108 | 2 | 8117269 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 28877685 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9566757 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8093002 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12469224 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31145702 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16133548 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8033246 | ||
| Pubmed | 1.58e-05 | 16 | 108 | 3 | 32675240 | ||
| Pubmed | 1.72e-05 | 102 | 108 | 5 | 9734811 | ||
| Pubmed | 2.38e-05 | 376 | 108 | 8 | 24154525 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 7695643 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 18259693 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 34461182 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 2.86e-05 | 3 | 108 | 2 | 21030649 | |
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 2.86e-05 | 3 | 108 | 2 | 24039991 | |
| Pubmed | Genetic analysis of indel markers in three loci associated with Parkinson's disease. | 2.86e-05 | 3 | 108 | 2 | 28873462 | |
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 2.86e-05 | 3 | 108 | 2 | 26067475 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 20676135 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 7961757 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 26455829 | ||
| Pubmed | 5.59e-05 | 549 | 108 | 9 | 38280479 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 25604459 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 9480752 | ||
| Pubmed | 7.57e-05 | 225 | 108 | 6 | 12168954 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 7.69e-05 | 72 | 108 | 4 | 8075499 | |
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 29346753 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 26169578 | ||
| Pubmed | 9.50e-05 | 5 | 108 | 2 | 36672770 | ||
| Pubmed | POLR1A RGPD8 DPH7 SPG11 KLHL9 POLR3B SUGP1 MIEF1 TMEM30A CDC5L | 9.85e-05 | 733 | 108 | 10 | 34672954 | |
| Pubmed | Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. | 1.42e-04 | 6 | 108 | 2 | 15358107 | |
| Pubmed | 1.42e-04 | 6 | 108 | 2 | 31054872 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 1.62e-04 | 370 | 108 | 7 | 22922362 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.66e-04 | 497 | 108 | 8 | 36774506 | |
| Pubmed | 1.96e-04 | 268 | 108 | 6 | 33640491 | ||
| Pubmed | 1.99e-04 | 7 | 108 | 2 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.99e-04 | 7 | 108 | 2 | 11353387 | |
| Interaction | SULT1A3 interactions | 1.24e-07 | 24 | 103 | 5 | int:SULT1A3 | |
| Interaction | SULT1A4 interactions | 6.19e-07 | 14 | 103 | 4 | int:SULT1A4 | |
| Interaction | SULT1C2 interactions | 2.35e-06 | 19 | 103 | 4 | int:SULT1C2 | |
| Interaction | RGPD2 interactions | 1.03e-05 | 27 | 103 | 4 | int:RGPD2 | |
| Interaction | SULT1C3 interactions | 2.08e-05 | 11 | 103 | 3 | int:SULT1C3 | |
| Interaction | SULT1A1 interactions | 2.38e-05 | 67 | 103 | 5 | int:SULT1A1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TCAP TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.86e-15 | 149 | 108 | 12 | chr17q12 |
| Cytoband | 17q12 | 1.38e-07 | 99 | 108 | 6 | 17q12 | |
| Cytoband | 17q21.33 | 1.26e-04 | 41 | 108 | 3 | 17q21.33 | |
| Cytoband | 16p12.1 | 1.59e-03 | 25 | 108 | 2 | 16p12.1 | |
| Cytoband | 9p22 | 1.59e-03 | 25 | 108 | 2 | 9p22 | |
| Cytoband | 3q13.2 | 2.44e-03 | 31 | 108 | 2 | 3q13.2 | |
| Cytoband | 12q23.3 | 3.10e-03 | 35 | 108 | 2 | 12q23.3 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.17e-09 | 14 | 67 | 5 | 762 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.34e-06 | 24 | 104 | 4 | MM1317 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 3.16e-06 | 157 | 104 | 7 | MM1099 | |
| Coexpression | LE_EGR2_TARGETS_DN | 7.39e-06 | 117 | 104 | 6 | MM1139 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.24e-05 | 75 | 104 | 5 | MM1084 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 6.32e-10 | 90 | 105 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TYK2 SULT1A4 SULT1A3 TBC1D3G TBC1D3K TBC1D3F | 1.49e-08 | 281 | 105 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TYK2 SULT1A4 SULT1A3 TBC1D3G TBC1D3K TBC1D3F | 1.49e-08 | 281 | 105 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | ERBB4 TRABD2B TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PRKCQ TBC1D3G TBC1D3K TBC1D3F | 6.23e-08 | 320 | 105 | 12 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TRABD2B TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 3.43e-07 | 242 | 105 | 10 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.13e-06 | 213 | 105 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G TBC1D3K TBC1D3F | 1.13e-06 | 213 | 105 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D PEPD TBC1D3C TBC1D3B TYK2 SULT1A2 SULT1A4 SULT1A1 SULT1A3 GLDC TBC1D3G EPAS1 DGAT1 TBC1D3K TBC1D3F | 3.62e-06 | 1049 | 105 | 18 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | BOC TBC1D3 STON1 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B PHLDB1 GLDC MAMDC2 C2orf49 TBC1D3G ZBTB18 TBC1D3K TBC1D3F | 7.46e-05 | 1075 | 105 | 16 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.97e-08 | 188 | 108 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-08 | 147 | 108 | 7 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 152 | 108 | 6 | eee86b508b8f140ea44e21d8c04c409a7b689e39 | |
| ToppCell | C_02|World / shred on cell type and cluster | 3.12e-06 | 165 | 108 | 6 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.31e-06 | 181 | 108 | 6 | c1fad1f03468523e563c039be520dcf7717f90cd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-06 | 182 | 108 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.40e-06 | 187 | 108 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-06 | 188 | 108 | 6 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.23e-06 | 191 | 108 | 6 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.23e-06 | 191 | 108 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.45e-06 | 192 | 108 | 6 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.67e-06 | 193 | 108 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Trm_gut_CD8|blood / Manually curated celltypes from each tissue | 3.69e-05 | 154 | 108 | 5 | c77a02df403358361aca86c679d5c43a64ff2f7f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-05 | 162 | 108 | 5 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 164 | 108 | 5 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 165 | 108 | 5 | dba630e205eb3725195f8861e4af5b745ccfdc74 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 165 | 108 | 5 | a508d66031c1a46b062afbee3cde1cbd0c163a03 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-05 | 165 | 108 | 5 | b03c8c3110f32257e78838885b313a922af73c98 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.08e-05 | 171 | 108 | 5 | 8a0c08f0aa3a80cd6346c81deb242e430ebd897b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.96e-05 | 176 | 108 | 5 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 6.96e-05 | 176 | 108 | 5 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 177 | 108 | 5 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.35e-05 | 178 | 108 | 5 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.35e-05 | 178 | 108 | 5 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.74e-05 | 180 | 108 | 5 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.74e-05 | 180 | 108 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.74e-05 | 180 | 108 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-05 | 181 | 108 | 5 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-05 | 182 | 108 | 5 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-05 | 182 | 108 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-05 | 182 | 108 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.16e-05 | 182 | 108 | 5 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.45e-05 | 95 | 108 | 4 | ffbf3e362384c87b9db690ed39cd215e1f68375c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-05 | 184 | 108 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.81e-05 | 185 | 108 | 5 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-05 | 186 | 108 | 5 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-05 | 186 | 108 | 5 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.27e-05 | 187 | 108 | 5 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 188 | 108 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.74e-05 | 189 | 108 | 5 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.99e-05 | 190 | 108 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.02e-04 | 191 | 108 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 54b7126b83f7482227aeaea065f504b65fa34bfe | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 196 | 108 | 5 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 196 | 108 | 5 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 1.18e-04 | 197 | 108 | 5 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.21e-04 | 198 | 108 | 5 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-04 | 198 | 108 | 5 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.24e-04 | 199 | 108 | 5 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-04 | 199 | 108 | 5 | f38e7bc3dc0e7822bee2df5634bf47a5c7145d60 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 199 | 108 | 5 | 0181c13379f869be47804cdb11bbdabcd30b9b23 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 199 | 108 | 5 | ee981046217e8759610eb58a670d98f32cd83abc | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| Drug | dopamine-4-O-sulfate | 1.12e-08 | 7 | 98 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.12e-08 | 7 | 98 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.12e-08 | 7 | 98 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.12e-08 | 7 | 98 | 4 | CID011953812 | |
| Drug | dopamine 3-O-sulfate | 2.23e-08 | 8 | 98 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.23e-08 | 8 | 98 | 4 | CID003037707 | |
| Drug | 2-iodophenol | 2.23e-08 | 8 | 98 | 4 | CID000010784 | |
| Drug | 1m2q | 8.16e-08 | 26 | 98 | 5 | CID005326637 | |
| Drug | barium hydroxide | 2.07e-07 | 31 | 98 | 5 | CID000028387 | |
| Drug | EM-139 | 2.24e-07 | 13 | 98 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 3.13e-07 | 14 | 98 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.13e-07 | 14 | 98 | 4 | CID000005888 | |
| Drug | arylsulfate | 4.25e-07 | 15 | 98 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 4.25e-07 | 15 | 98 | 4 | CID000002895 | |
| Drug | A-44 | 5.64e-07 | 16 | 98 | 4 | CID000120353 | |
| Drug | benzilic acid | 7.36e-07 | 17 | 98 | 4 | CID000006463 | |
| Drug | d-equilenin | 8.83e-07 | 41 | 98 | 5 | CID000010597 | |
| Drug | L-alpha-methyldopa | 9.99e-07 | 42 | 98 | 5 | CID000004138 | |
| Drug | AC1Q6OHG | 1.19e-06 | 19 | 98 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.19e-06 | 19 | 98 | 4 | CID000442688 | |
| Drug | NSC674039 | 1.27e-06 | 44 | 98 | 5 | CID000001249 | |
| Drug | PLP-Glu | 1.48e-06 | 20 | 98 | 4 | CID000444293 | |
| Drug | 4-octylphenol | 1.77e-06 | 47 | 98 | 5 | CID000015730 | |
| Drug | N-hydroxy-2-aminofluorene | 1.83e-06 | 21 | 98 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.22e-06 | 22 | 98 | 4 | CID000062244 | |
| Drug | AABSSN | 2.22e-06 | 22 | 98 | 4 | CID005464134 | |
| Drug | AC1L577W | 2.67e-06 | 7 | 98 | 3 | CID000171279 | |
| Drug | Phosphoadenosine Phosphosulfate | 2.67e-06 | 7 | 98 | 3 | ctd:D010724 | |
| Drug | taselin | 2.68e-06 | 23 | 98 | 4 | CID000023846 | |
| Drug | AalphaC | 3.21e-06 | 24 | 98 | 4 | CID000062805 | |
| Drug | minoxidil | 3.57e-06 | 54 | 98 | 5 | CID000004201 | |
| Drug | androstenediol | 3.57e-06 | 54 | 98 | 5 | CID000010634 | |
| Drug | AzMC | 3.81e-06 | 25 | 98 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 3.81e-06 | 25 | 98 | 4 | CID000004202 | |
| Drug | 2-pentanone | 3.81e-06 | 25 | 98 | 4 | CID000007895 | |
| Drug | N-hydroxy-4-aminobiphenyl | 4.26e-06 | 8 | 98 | 3 | ctd:C014593 | |
| Drug | alpha-methyldopamine | 4.49e-06 | 26 | 98 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 4.49e-06 | 26 | 98 | 4 | CID000115245 | |
| Drug | Glu-P-2 | 7.06e-06 | 29 | 98 | 4 | CID000049970 | |
| Drug | 3,3'-T2 | 8.12e-06 | 30 | 98 | 4 | CID000065559 | |
| Drug | 4-nonylphenol | 8.31e-06 | 64 | 98 | 5 | CID000001752 | |
| Drug | A2'p5'A2'p5'A | 9.29e-06 | 31 | 98 | 4 | CID000122642 | |
| Drug | acetaminophen sulfate | 9.29e-06 | 31 | 98 | 4 | CID000083939 | |
| Drug | DCNP | 1.20e-05 | 33 | 98 | 4 | CID000012066 | |
| Drug | 7-hydroxycoumarin | 1.81e-05 | 75 | 98 | 5 | CID005281426 | |
| Drug | Hydroxytryptophol | 1.83e-05 | 2 | 98 | 2 | ctd:D006917 | |
| Drug | 5-hydroxymethylfurfural | 1.83e-05 | 2 | 98 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 1.83e-05 | 2 | 98 | 2 | ctd:C012365 | |
| Drug | mefenamic acid | 1.91e-05 | 37 | 98 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 2.13e-05 | 38 | 98 | 4 | CID000007518 | |
| Drug | Phenacetin [62-44-2]; Up 200; 22.4uM; PC3; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 3992_UP | |
| Drug | 4-hydroxyestradiol | 2.33e-05 | 79 | 98 | 5 | CID000001743 | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.40e-05 | 198 | 98 | 7 | 6525_DN | |
| Drug | Woodward's reagent K | 3.50e-05 | 43 | 98 | 4 | CID000077804 | |
| Drug | NDPS | 4.20e-05 | 45 | 98 | 4 | CID000090363 | |
| Drug | 1IIg | 4.20e-05 | 45 | 98 | 4 | CID000001682 | |
| Drug | sulfamethazine | 5.43e-05 | 48 | 98 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 5.43e-05 | 48 | 98 | 4 | CID000005896 | |
| Drug | salicylamide | 5.43e-05 | 48 | 98 | 4 | CID000005147 | |
| Drug | 8-azaadenine | 5.49e-05 | 3 | 98 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 5.49e-05 | 3 | 98 | 2 | ctd:C030629 | |
| Drug | 5-hydroxy-3-methylindole | 5.49e-05 | 3 | 98 | 2 | CID000192734 | |
| Drug | ethyl glyoxalate | 5.49e-05 | 3 | 98 | 2 | CID000070211 | |
| Drug | 5-hydroxyindole | 5.49e-05 | 3 | 98 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 5.49e-05 | 3 | 98 | 2 | ctd:D008914 | |
| Drug | 1-naphthol | 6.60e-05 | 98 | 98 | 5 | CID000007005 | |
| Drug | 1-hydroxypyrene | 6.91e-05 | 51 | 98 | 4 | ctd:C033146 | |
| Drug | AB-4 | 7.13e-05 | 19 | 98 | 3 | CID001367558 | |
| Drug | estrone sulfate | 7.51e-05 | 163 | 98 | 6 | CID000000699 | |
| Drug | 9-hydroxybenzo(a)pyrene | 8.04e-05 | 53 | 98 | 4 | CID000028598 | |
| Drug | sodium phosphate monohydrate | 8.36e-05 | 20 | 98 | 3 | CID000061456 | |
| Drug | estrone-d4 | 8.87e-05 | 168 | 98 | 6 | CID000000698 | |
| Drug | MeIQx | 9.30e-05 | 55 | 98 | 4 | CID000062275 | |
| Drug | 4-NA | 1.09e-04 | 4 | 98 | 2 | CID006102690 | |
| Drug | Chebi:32701 | 1.09e-04 | 4 | 98 | 2 | CID005460855 | |
| Drug | phenothrin | 1.12e-04 | 22 | 98 | 3 | CID000004767 | |
| Drug | 2-naphthylamine | 1.14e-04 | 110 | 98 | 5 | CID000007057 | |
| Drug | NSC36919 | 1.15e-04 | 58 | 98 | 4 | CID000235496 | |
| Drug | 4-hydroxyestrone | 1.22e-04 | 59 | 98 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.22e-04 | 59 | 98 | 4 | CID000083944 | |
| Drug | 1-hydroxymethylpyrene | 1.29e-04 | 23 | 98 | 3 | CID000104977 | |
| Drug | apixaban | 1.47e-04 | 24 | 98 | 3 | CID010182969 | |
| Drug | 3-OHBaP | 1.58e-04 | 63 | 98 | 4 | CID000025890 | |
| Drug | 2-hydroxyestradiol | 1.66e-04 | 25 | 98 | 3 | ctd:C001390 | |
| Drug | acetaminophen | 1.68e-04 | 270 | 98 | 7 | CID000001983 | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.69e-04 | 189 | 98 | 6 | 2695_UP | |
| Drug | pentachlorophenol | 1.72e-04 | 120 | 98 | 5 | CID000000992 | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 190 | 98 | 6 | 4421_DN | |
| Drug | epicatechin-3-gallate | 1.79e-04 | 65 | 98 | 4 | CID000065056 | |
| Drug | 16-ketoestrone | 1.82e-04 | 5 | 98 | 2 | ctd:C002591 | |
| Drug | harmol | 1.82e-04 | 5 | 98 | 2 | ctd:C001326 | |
| Drug | pinocembrin | 1.82e-04 | 5 | 98 | 2 | ctd:C016063 | |
| Drug | TKPP | 1.82e-04 | 5 | 98 | 2 | CID000023740 | |
| Drug | PhIP-HCl | 1.93e-04 | 123 | 98 | 5 | CID000001530 | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 195 | 98 | 6 | 2820_DN | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 195 | 98 | 6 | 5428_DN | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A | 2.00e-04 | 195 | 98 | 6 | 3047_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 98 | 6 | 5438_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 98 | 6 | 3892_DN | |
| Drug | valienamine | 2.08e-04 | 125 | 98 | 5 | CID000193758 | |
| Disease | Chromosome Aberrations | 1.70e-05 | 16 | 94 | 3 | C0008625 | |
| Disease | Autosome Abnormalities | 1.70e-05 | 16 | 94 | 3 | C0004403 | |
| Disease | longitudinal BMI measurement | 1.40e-04 | 82 | 94 | 4 | EFO_0005937 | |
| Disease | Respiratory Tract Diseases | 1.49e-04 | 6 | 94 | 2 | C0035242 | |
| Disease | polycythemia (is_implicated_in) | 1.49e-04 | 6 | 94 | 2 | DOID:8432 (is_implicated_in) | |
| Disease | Myopathies, Nemaline | 2.78e-04 | 8 | 94 | 2 | C0206157 | |
| Disease | renal cell carcinoma | 3.28e-04 | 42 | 94 | 3 | EFO_0000681 | |
| Disease | Carcinoma, Granular Cell | 5.27e-04 | 116 | 94 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.27e-04 | 116 | 94 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.27e-04 | 116 | 94 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.27e-04 | 116 | 94 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.27e-04 | 116 | 94 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.27e-04 | 116 | 94 | 4 | C0001418 | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 6.49e-04 | 12 | 94 | 2 | DOID:4914 (is_marker_for) | |
| Disease | Night blindness, congenital stationary, type 1 | 6.49e-04 | 12 | 94 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 6.49e-04 | 12 | 94 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 6.49e-04 | 12 | 94 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 6.49e-04 | 12 | 94 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 6.49e-04 | 12 | 94 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 6.49e-04 | 12 | 94 | 2 | C1848172 | |
| Disease | X-12707 measurement | 6.49e-04 | 12 | 94 | 2 | EFO_0800720 | |
| Disease | uric acid measurement | 7.46e-04 | 610 | 94 | 8 | EFO_0004761 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 7.65e-04 | 13 | 94 | 2 | C4041558 | |
| Disease | Depressed mood | 7.65e-04 | 13 | 94 | 2 | C0344315 | |
| Disease | triglycerides in very large VLDL measurement | 7.68e-04 | 56 | 94 | 3 | EFO_0022325 | |
| Disease | ascorbic acid 3-sulfate measurement | 8.91e-04 | 14 | 94 | 2 | EFO_0800173 | |
| Disease | triglycerides in VLDL measurement | 8.94e-04 | 59 | 94 | 3 | EFO_0022326 | |
| Disease | myocardial infarction | 9.05e-04 | 350 | 94 | 6 | EFO_0000612 | |
| Disease | macrophage inflammatory protein 1b measurement | 9.55e-04 | 136 | 94 | 4 | EFO_0008219 | |
| Disease | triglycerides in small VLDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022274 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 9.86e-04 | 61 | 94 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | mean reticulocyte volume | 1.02e-03 | 799 | 94 | 9 | EFO_0010701 | |
| Disease | triglycerides in medium LDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022322 | |
| Disease | total lipids in very large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022299 | |
| Disease | triglycerides in small LDL measurement | 1.19e-03 | 65 | 94 | 3 | EFO_0022323 | |
| Disease | free androgen index | 1.27e-03 | 374 | 94 | 6 | EFO_0007005 | |
| Disease | esophageal carcinoma, gastric carcinoma | 1.32e-03 | 17 | 94 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | Night blindness, congenital stationary | 1.32e-03 | 17 | 94 | 2 | C0339535 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.35e-03 | 68 | 94 | 3 | EFO_0022327 | |
| Disease | breast cancer (is_implicated_in) | 1.37e-03 | 150 | 94 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | coronary artery disease | ERBB4 C5orf67 STON1 TTC41P KSR2 ACAD10 ABHD5 RASGEF1B GIGYF2 PMFBP1 WDR72 | 1.46e-03 | 1194 | 94 | 11 | EFO_0001645 |
| Disease | alkaline phosphatase measurement | C5orf67 CHD3 ACAD10 PHLDB1 SUGP1 MIEF1 SLC13A5 CDC5L DGAT1 PMFBP1 | 1.47e-03 | 1015 | 94 | 10 | EFO_0004533 |
| Disease | stomach cancer (is_implicated_in) | 1.59e-03 | 72 | 94 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | CCL4 measurement | 1.84e-03 | 20 | 94 | 2 | EFO_0004751 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 1.84e-03 | 20 | 94 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | triglyceride measurement, body fat percentage | 2.03e-03 | 21 | 94 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Granulomatous Slack Skin | 2.23e-03 | 22 | 94 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 2.43e-03 | 23 | 94 | 2 | C0079773 | |
| Disease | Coronary heart disease | 2.65e-03 | 24 | 94 | 2 | C0010068 | |
| Disease | stomach carcinoma (is_marker_for) | 2.65e-03 | 24 | 94 | 2 | DOID:5517 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.72e-03 | 181 | 94 | 4 | DOID:684 (is_implicated_in) | |
| Disease | TEMPS-A questionnaire | 2.87e-03 | 25 | 94 | 2 | EFO_0004783 | |
| Disease | Cardiac Arrhythmia | 2.87e-03 | 25 | 94 | 2 | C0003811 | |
| Disease | pre-eclampsia (is_implicated_in) | 2.87e-03 | 25 | 94 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | body fat percentage, high density lipoprotein cholesterol measurement | 2.87e-03 | 25 | 94 | 2 | EFO_0004612, EFO_0007800 | |
| Disease | Cholangiocarcinoma | 3.10e-03 | 26 | 94 | 2 | C0206698 | |
| Disease | Depressive Symptoms | 3.10e-03 | 26 | 94 | 2 | C0086132 | |
| Disease | macula measurement | 3.17e-03 | 189 | 94 | 4 | EFO_0008375 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PQRDLPKNRWGKMME | 61 | Q9BVC5 | |
| NADGGKMPIKWMALE | 876 | Q15303 | |
| MWKRMKNLRGGSCPL | 736 | Q99814 | |
| MPRIMIKGGVWRNTE | 1 | Q99459 | |
| TTEAMLKQGWTPRRM | 906 | P12821 | |
| MKLGFSRPWPEAMQL | 1171 | P12821 | |
| MKTLPAMLGTGKLFW | 1 | Q7Z6A9 | |
| PMKGRKGMVDWARNS | 721 | O60242 | |
| LTPSGWAKLMSMIKS | 191 | Q8NHS2 | |
| VMGMLWRRLNDSGKN | 56 | Q9H201 | |
| LKALMEGGENGPWMR | 76 | Q6JQN1 | |
| KPMLRRGSSKWMART | 391 | O75907 | |
| APGLIKTSFSRMLWM | 211 | Q9BTZ2 | |
| PMMELKPNAGSDRAW | 106 | P43487 | |
| RSSRAVMGAMKPGVW | 311 | P12955 | |
| TMNLKPLSGSDRAWM | 1116 | Q99666 | |
| TMNLKPLSGSDRAWM | 1116 | O14715 | |
| MLLKGSLQPGMWEST | 206 | O75747 | |
| CKKVIGGMVWNPAMR | 341 | P26045 | |
| GGMVWNPAMRRSLSV | 346 | P26045 | |
| EAQKMSSLLPTMWLG | 961 | O60271 | |
| RGVWMQAEITFKKPM | 451 | Q7Z304 | |
| TPEAWRVMMSLKSGL | 1666 | O14497 | |
| LWTMSRPGAKKVMNS | 16 | Q9Y442 | |
| WLELKPQGRMLMNAR | 106 | Q04759 | |
| MGLMWRSIDHPGKLI | 341 | Q92731 | |
| VRQMPGKGLEWMGRI | 56 | A0A0J9YXX1 | |
| MGKLIRMGPQERWLL | 1 | O60721 | |
| TLMGNPWFQRAKMPR | 251 | Q8IU57 | |
| AIIWQMGTGMKPNLS | 881 | Q6VAB6 | |
| ELTRKMRRDGWPAMG | 356 | P17844 | |
| PEMLGLQNRWRGMKN | 66 | Q4VX62 | |
| LSGWKDNPAMPAGLM | 251 | Q6ZQW0 | |
| GKDPRWATMADLKMQ | 736 | O43896 | |
| DKWMQKAPMTTVRGL | 471 | Q9P2J3 | |
| WMGSPRLLNRDMKTG | 76 | Q9NQG6 | |
| MLKGQPIRIMWSQRD | 76 | Q4VXU2 | |
| GMNMSPVSRLKKTWA | 311 | Q0VAM2 | |
| VRQMPGKGLEWMGII | 56 | A0A0C4DH38 | |
| ANKWMMVAPLRDGVS | 421 | Q9H0H3 | |
| MLRGTMTAWRGMRPE | 1 | Q9BWV1 | |
| LRLMMPGAWTKLPGD | 56 | F2Z3F1 | |
| SFQPLGDIMKMWGRV | 576 | Q6Y7W6 | |
| MKPLTEGMRKNGTWL | 396 | Q9BTV6 | |
| KWMPFTNPARKDGAM | 96 | Q9NPF5 | |
| RMSNAKNWLGLGMSL | 6 | Q9HBT6 | |
| PMSKMMTILGAKWRE | 181 | Q12873 | |
| QQMMRWLKGERPGPE | 391 | Q5T2N8 | |
| YRWKMNGTEMKLEPG | 71 | Q02246 | |
| RKWTNLSDPMPVGQM | 186 | Q8NFQ5 | |
| GRKRMILSTISWMGG | 306 | Q9NV96 | |
| DWKRGKMLSMAPGHT | 136 | Q05BV3 | |
| RVWNMTATRPKKMGS | 66 | Q969F0 | |
| WVGAKPARLMLGFMG | 116 | Q86YT5 | |
| ASGLSVWMGKQMEPL | 426 | Q86YT5 | |
| MVGRMFKRDGNPWLT | 76 | Q8WXA2 | |
| TMNLKPLSGSDRAWM | 1101 | P0DJD0 | |
| MWTLLKQLRPGMDLS | 371 | Q9H0X9 | |
| ALKLGMMPLWTKDGQ | 101 | P09001 | |
| TLGWKGLPQDMGQRM | 976 | Q8TBY8 | |
| MKRKEMIGWISLGLN | 511 | Q8NB59 | |
| MLISKNMPWRRLQGI | 1 | O95602 | |
| SMKMWKLSTSGNRPP | 1411 | A6NHR9 | |
| ISPFMRKGMPGDWKN | 261 | Q6IMI6 | |
| ATPRRRMPGLGWMKK | 2966 | Q8WUY3 | |
| MKMPSQKGLSGDWAL | 1271 | Q5QGS0 | |
| GALLRKVPSWAMDMN | 981 | Q6ZNJ1 | |
| WLMGAPAGLKMNRAL | 326 | Q9BRB3 | |
| VQRSPWLMMRMGILG | 61 | O15273 | |
| GMPMNIRGPMWSVLL | 101 | B9A6J9 | |
| SISPFMRKGMAGDWK | 251 | P0DMN0 | |
| SISPFMRKGMAGDWK | 251 | P0DMM9 | |
| GWAKRPMLQRIGKMH | 271 | Q8WTS1 | |
| RSMGSPRPKTTWMKA | 451 | P35612 | |
| RWFGVAPPKSGKMNM | 16 | Q8IWZ8 | |
| SWGTAAMGRVLPMLL | 16 | Q96JI7 | |
| GMPMNIRGPMWSVLL | 101 | A6NDS4 | |
| GMPMNIRGPMWSVLL | 101 | P0C7X1 | |
| PKGWMQARMLFKESR | 651 | Q6ZU65 | |
| RIPEKKNMMSSRQWG | 281 | Q9Y6Q2 | |
| KNMMSSRQWGPIFLK | 286 | Q9Y6Q2 | |
| AAKMRGGFWPALRMN | 141 | Q9NR77 | |
| GMPMNIRGPMWSVLL | 101 | A6NER0 | |
| MMPSWMTPAQRGKGL | 131 | A6NFA1 | |
| SISPFMRKGMAGDWK | 251 | P50225 | |
| SISPFMRKGMAGDWK | 251 | P50226 | |
| PSKRDLAAEPGNMWM | 171 | Q99592 | |
| LMLPGWDLCNSGMIK | 841 | Q3MJ13 | |
| ELPWHMKMSGCLRGL | 721 | Q6P2S7 | |
| ISKPPMGTWMGLLNN | 586 | O94885 | |
| MSPEHAMRLWGRGVK | 126 | Q9P273 | |
| KMMLLHWRPSQRGSK | 346 | Q8NFJ6 | |
| MGPMLDAATRKPIWR | 791 | Q9NW08 | |
| GMPMNIRGPMWSVLL | 101 | A0A087X179 | |
| AEAKWMKSMIPAGGR | 136 | Q86UU1 | |
| MLKWDNGPDGRRVMQ | 586 | Q14166 | |
| LDLGKMMIQWNGPKT | 166 | O15195 | |
| MWMGRLRMRKNPGLK | 736 | Q7Z4N2 | |
| RKSQPMGLWRQVEGM | 66 | P25311 | |
| MAGSGAWKRLKSMLR | 1 | O14863 | |
| GMPMNIRGPMWSVLL | 101 | A0A087WVF3 | |
| GMPMNIRGPMWSVLL | 101 | Q6DHY5 | |
| GMPMNIRGPMWSVLL | 101 | Q8IZP1 | |
| GMPMNIRGPMWSVLL | 101 | A0A087X1G2 | |
| LEMWLMPQGSLKLLG | 621 | Q9H1B5 | |
| GMPMNIRGPMWSVLL | 101 | A0A087WXS9 | |
| GMPMNIRGPMWSVLL | 101 | Q6IPX1 | |
| MPLRHWGMARGSKPV | 1 | P29597 | |
| PGKRSQLWRMTGTGM | 3641 | Q5THJ4 | |
| LPISWAYIKMMGGKG | 811 | P23378 | |
| GARNIKDDPKMMWSI | 3536 | P20929 | |
| MGELVNTPSWMDKGL | 11 | Q9HD90 |